COVID-19: Clinical features and outcomes in unvaccinated 2-dose and 3-dose vaccinated against SARS-CoV-2 patients with systemic autoimmune and autoinflammatory rheumatic diseases

mRNA vaccine-elicited antibodies to SARS-CoV-2 and circulating variants

Zijun Wang, Fabian Schmidt, Yiska Weisblum et al. · Nature · 2021 · 1.5K citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

Milena Gianfrancesco, Kimme L Hyrich, Sarah Al-Adely et al. · Annals of the Rheumatic Diseases · 2020 · 1.2K citations · Full text

Medicine, Infectious Diseases, Internal Medicine +16

Vaccine Breakthrough Infections with SARS-CoV-2 Variants

Ezgi Hacisuleyman, Caryn Hale, Yuhki Saito et al. · New England Journal of Medicine · 2021 · 811 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

Anja Strangfeld, Martin Schäfer, Milena Gianfrancesco et al. · Annals of the Rheumatic Diseases · 2021 · 691 citations · Full text

Medicine, Internal Medicine, Clinical Epidemiology +8

Immunogenicity and safety of the BNT162b2 mRNA COVID-19 vaccine in adult patients with autoimmune inflammatory rheumatic diseases and in the general population: a multicentre study

Victoria Furer, Tali Eviatar, Devy Zisman et al. · Annals of the Rheumatic Diseases · 2021 · 691 citations · Full text

Veterinary Medicine, Immunology, Autoimmunity +15